For the first time, we analyzed the relationship between TP53 mutations and SPOP mutations using large sample sequencing data and systematically analyzed the effect of different TP53 mutation status on OS in SPOP-mutated metastatic PCa patients. The gene discussed is TP53; the disease is posterior cortical atrophy.